Search - tctmd.com

Displaying 121 - 140 of 161

Sort: Relevancy | Date

Conversations in Cardiology: Uncovered Struts on OCT After 12 Years?

News Opinion Conversations in Cardiology

Conversations in Cardiology: Uncovered Struts on OCT After 12 Years?

March 27, 2020

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

News Daily News

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Yael L. Maxwell

March 10, 2020

Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk

News Daily News

Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk

Yael L. Maxwell

March 03, 2020

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

February 28, 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

News Conference News CRT 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

February 25, 2020

Cirrhosis Tied to Poor Outcomes in the Months After PCI

News Daily News

Cirrhosis Tied to Poor Outcomes in the Months After PCI

February 12, 2020

ACS After TAVR a Unique Condition With Poor Prognosis

News Daily News

ACS After TAVR a Unique Condition With Poor Prognosis

February 05, 2020

SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE

News Daily News

SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE

Michael O'Riordan

February 03, 2020

The Cancer Patient Needing PCI Poses Conundrums for Care

News Features

The Cancer Patient Needing PCI Poses Conundrums for Care

January 14, 2020

Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR?

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR?

January 02, 2020

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

News Daily News

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

December 02, 2019

Women Bleed More Than Men After PCI, GLOBAL LEADERS Affirms

News Daily News

Women Bleed More Than Men After PCI, GLOBAL LEADERS Affirms

November 07, 2019

Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD

News Daily News

Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD

October 29, 2019

Sex-Specific Troponin Cutoffs Find Many More Women With Myocardial Injury

News Daily News

Sex-Specific Troponin Cutoffs Find Many More Women With Myocardial Injury

October 14, 2019

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

News Conference News TCT 2019

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

October 08, 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

October 03, 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

September 26, 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

September 26, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.